People who carry the schizophrenia genes could be at a higher risk of seeing their IQ decrease with age, even if they do not develop the condition.
Scientists at the University of Edinburgh say the findings could lead to new research into how different genes for schizophrenia affect brain function over time. They also show that genes associated with schizophrenia influence people in other important ways besides causing the illness itself.
Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.
Advertisement
The researchers used the latest genetic analysis techniques to reach their conclusion on how thinking skills change with age.
They compared the IQ scores of more than 1,000 people from Edinburgh who were tested for general cognitive functions in 1947, when the subjects were aged 11, and again when they were around 70 years old.
![Antipsychotic Drugs and Relapsing Schizophrenia]( "Antipsychotic Drugs and Relapsing Schizophrenia")
Schizophrenia is a chronic distressing and debilitating ailment. About 80% of the patients report recurrence within 5 years. Antipsychotic drugs are effective in keeping a check on this recurrence.
The researchers were able to examine people's genes and calculate each subject's genetic likelihood of developing schizophrenia, even though none of the group had ever developed the illness.
They then compared the IQ scores of people with a high and low risk of developing schizophrenia. They found that there was no difference at age 11, but people with a greater genetic risk of schizophrenia had slightly lower IQs at age 70.
Those people who had more genes linked to schizophrenia also had a greater estimated fall in IQ over their lifetime than those at lower risk.
Ian Deary, Director of the University of Edinburgh's Center for Cognitive Aging and Cognitive Epidemiology, who led the research team, said: "Retaining our thinking skills as we grow older is important for living well and independently. If nature has loaded a person's genes towards schizophrenia, then there is a slight but detectable worsening in cognitive functions between childhood and old age."
Andrew McIntosh, of the University of Edinburgh's Center for Clinical Brain Sciences, said: "With further research into how these genes affect the brain, it could become possible to understand how genes linked to schizophrenia affect people's cognitive functions as they age."
Source: Eurekalert
Antipsychotic Drugs and Relapsing Schizophrenia
Schizophrenia is a chronic distressing and debilitating ailment. About 80% of the patients report recurrence within 5 years. Antipsychotic drugs are effective in keeping a check on this recurrence.
Advertisement
The researchers were able to examine people's genes and calculate each subject's genetic likelihood of developing schizophrenia, even though none of the group had ever developed the illness.
They then compared the IQ scores of people with a high and low risk of developing schizophrenia. They found that there was no difference at age 11, but people with a greater genetic risk of schizophrenia had slightly lower IQs at age 70.
Those people who had more genes linked to schizophrenia also had a greater estimated fall in IQ over their lifetime than those at lower risk.
Ian Deary, Director of the University of Edinburgh's Center for Cognitive Aging and Cognitive Epidemiology, who led the research team, said: "Retaining our thinking skills as we grow older is important for living well and independently. If nature has loaded a person's genes towards schizophrenia, then there is a slight but detectable worsening in cognitive functions between childhood and old age."
Andrew McIntosh, of the University of Edinburgh's Center for Clinical Brain Sciences, said: "With further research into how these genes affect the brain, it could become possible to understand how genes linked to schizophrenia affect people's cognitive functions as they age."
Source: Eurekalert
Antidiabetic GLP-1 Analogs May Benefit Schizophrenia Patients With Antipsychotic-Induced Weight Gain
GLP-1 analogs used to treat diabetes may also help with weight loss in schizophrenia patients with anti-psychotic induced weight gain.
Advertisement
 Schizophrenia Destigmatized - SCARF an NGO Shows the Way ForwardDr. R.Thara, Director of SCARF (Schizophrenia Research Foundation) interview on the challenge of diagnosing, treating and rehabilitating people with schizophrenia. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.